Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor containing regimen.

Catia MarzoliniMatthias CavassiniDominique L BraunAnna HachfeldEnos BernasconiAlexandra CalmyPatrick SchmidManuel BattegayLuigia Elzinull null

Published in: British journal of clinical pharmacology (2023)

The lipid lowering effect of statins tended to be attenuated by SLCO1B1 polymorphism and progressively declined as total cholesterol under the boosted protease inhibitor treatment decreased.

Keyphrases

cardiovascular disease
fatty acid